All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Scientific meetings were canceled, and research data on the bird flu outbreak was delayed, amid confusion over the directive.
The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ...